Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Comparison Between Ultra Early NKF Versus Standard Cannulation Alone in a Group of High and Low Risk of Pep, Submitted to Pep Prophylaxis

NCT04492137 is registered in ClinicalTrials.gov with University of Minho as lead sponsor.

NCT NCT04492137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04492137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Comparison Between Ultra Early NKF Versus Standard Cannulation Alone in a Group of High and Low Risk of Pep, Submitted to Pep Prophylaxis
Lead sponsor
University of Minho
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2020
Completion date
June 30, 2022
Enrollment
334 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis